Advertisement
Clinical Research| Volume 74, P246-257, July 2021

Mycotic Abdominal Aortic Aneurysms – A Tertiary Centre Experience and Formulation of a Management Protocol

Published:January 25, 2021DOI:https://doi.org/10.1016/j.avsg.2020.12.025

      Background

      Mycotic abdominal aorta aneurysm (MAAA) is a rare and life-threatening condition. Because of its rarity, there is a lack of adequately powered studies and consensus on its treatment and follow up. This study aimed to review the outcomes following surgical intervention for MAAA in a single tertiary centre and to formulate a management protocol based on available evidence and expert opinion.

      Materials and Methods

      Data were collected by retrospective review of case records of all patients who underwent repair of MAAA in a single tertiary referral centre from 2001 to 2018. Demographic, clinical and outcome data were analysed and compared with previously published series in the literature. A management protocol was formulated based on available literature which was then reviewed and modified as per expert opinion from multidisciplinary discussions.

      Results

      Seventeen patients underwent repair of MAAA during the study period including 4 Open repairs, 4 surgeon modified fenestrated endovascular aortic aneurysm repairs (SM FEVAR) and 9 endovascular aortic aneurysm repairs (EVAR). One-year overall survival was 94.1%, 3-year survival was 81.8% and 5-year survival was 75.0%. The infection-free survival at 1, 3, and 5 years was 87.5%, 81.8% and 62.5%, respectively. The overall survival and infection-free survival curves for Open repair, EVAR and SM FEVAR when compared using Log Rank (Mantel-Cox) test and did not show any statistically significant difference.

      Conclusions

      Management of MAAA with selective use of open or endovascular repair, in combination with appropriate long-term antibiotic therapy, can achieve acceptable outcomes. The proposed protocol can aid as a guiding document for the management of MAAA but needs taking into consideration individual patient variability and local expertise.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Osler W.
        The Gulstonian lectures, on malignant endocarditis.
        Br Med J. 1885; 1: 467-470https://doi.org/10.1136/bmj.1.1262.467
        • Kilic A
        • Arnaoutakis DJ
        • Reifsnyder T
        • et al.
        Management of infected vascular grafts.
        Vascular Medicine (United Kingdom). 2016; 21: 53-60https://doi.org/10.1177/1358863X15612574
        • Fichelle JM
        • Tabet G
        • Cormier P
        • et al.
        Infected infrarenal aortic aneurysms: when is in situ reconstruction safe?.
        J Vasc Surg. 1993; 17: 635-645https://doi.org/10.1016/0741-5214(93)90105-U
        • Anderson CB
        • Butcher HR
        • Ballinger WF.
        Mycotic aneurysms.
        Arch Surg. 1974; 109: 712-717https://doi.org/10.1001/archsurg.1974.01360050106022
        • Luo C yau
        • Ko WC
        • Lee HC
        • et al.
        Relapsing melioidosis as cause of iliac mycotic aneurysm: an indigenous case in Taiwan.
        J Vasc Surg. 2003; 37: 882-885https://doi.org/10.1067/mva.2003.164
        • Miller D.V.
        • GS Oderich
        • Aubry MC
        • et al.
        Surgical pathology of infected aneurysms of the descending thoracic and abdominal aorta: clinicopathologic correlations in 29 cases (1976 to 1999).
        Hum Pathol. 2004; 35: 1112-1120https://doi.org/10.1016/j.humpath.2004.05.013
        • Gornik HL
        • Creager MA
        Aortitis.
        Circulation. 2008; 117: 3039-3051https://doi.org/10.1161/CIRCULATIONAHA.107.760686
        • Oderich GS
        • Panneton JM
        • Bower TC
        • et al.
        Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results.
        J Vasc Surg. 2001; 34: 900-908https://doi.org/10.1067/mva.2001.118084
        • Müller BT
        • Wegener OR
        • Grabitz K
        • et al.
        Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases.
        J Vasc Surg. 2001; 33: 106-113https://doi.org/10.1067/mva.2001.110356
        • Fichelle JM
        • Tabet G
        • Cormier P
        • et al.
        Infected infrarenal aortic aneurysms: when is in situ reconstruction safe?.
        J Vasc Surg. 1993; 17: 635-645https://doi.org/10.1016/0741-5214(93)90105-U
        • Reddy DJ
        • Shepard AD
        • Evans JR
        • et al.
        Management of infected aortoiliac aneurysms.
        Arch Surg. 1991; 126: 873-879https://doi.org/10.1001/archsurg.1991.01410310083012
        • Sörelius K
        • di Summa PG.
        On the diagnosis of mycotic aortic aneurysms.
        Clin Med Insights: Cardiol. 2018; 12117954681875967https://doi.org/10.1177/1179546818759678
        • Semba CP
        • Sakai T
        • Slonim SM
        • et al.
        Mycotic aneurysms of the thoracic aorta: repair with use of endovascular stent-grafts.
        J Vasc Interv Radiol. 1998; 9: 33-40https://doi.org/10.1016/S1051-0443(98)70479-8
        • Lin CH
        • bin Hsu R
        Primary infected aortic aneurysm: clinical presentation, pathogen, and outcome.
        Acta Cardiologica Sinica. 2014; 30: 514-521https://doi.org/10.6515/ACS20140630A
        • Di X
        • Ye W
        • Liu CW
        • et al.
        Fenestrated endovascular repair for pararenal abdominal aortic aneurysms: a systematic review and meta-analysis.
        Ann Vasc Surg. 2013; 27: 1190-1200https://doi.org/10.1016/j.avsg.2013.06.003
        • Singh A
        • Mafeld S
        • Williams R
        • et al.
        Physician-modified fenestrated endografts for managing the ruptured or symptomatic aortic aneurysm: technique overview and clinical outcomes.
        Vasc Endovascular Surg. 2018; 52: 607-612https://doi.org/10.1177/1538574418789023
        • Scali ST
        • Neal D
        • Sollanek V
        • et al.
        Outcomes of surgeon-modified fenestrated-branched endograft repair for acute aortic pathology Presented at the Plenary Session at the Thirty-ninth Annual Meeting of the Southern Association for Vascular Surgery, Scottsdale, Ariz, January 14-17, 2015.
        J Vasc Surg. 2015; 62 (Mosby Inc.e2https://doi.org/): 1148-1159https://doi.org/10.1016/j.jvs.2015.06.133
        • Sule JA
        • Dharmaraj RB.
        Surgeon modified fenestrated endovascular abdominal aortic repair (F-EVAR) for subacute multifocal mycotic abdominal and iliac artery saccular aneurysms.
        EJVES Short Rep. 2016; 32: 7-11https://doi.org/10.1016/j.ejvssr.2016.03.007
        • Sörelius K
        • Wanhainen A
        • Furebring M
        • et al.
        Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair.
        Circulation. 2016; 134: 1822-1832https://doi.org/10.1161/CIRCULATIONAHA.116.024021
        • Wanhainen A
        • Verzini F
        • van Herzeele I
        • et al.
        European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms.
        Eur J Vasc Endovasc Surg. 2018; https://doi.org/10.1016/j.ejvs.2018.09.020
        • Sörelius K
        • Mani K
        • Björck M.
        Endovascular treatment of mycotic aortic aneurysms: a European multicenter study.
        J Vasc Surg. 2015; https://doi.org/10.1016/j.jvs.2015.01.020
        • Sörelius K
        • Wanhainen A
        • Furebring M
        • et al.
        Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair.
        Circulation. 2016; 134: 1822-1832https://doi.org/10.1161/CIRCULATIONAHA.116.024021
        • Kan CD
        • Lee HL
        • Yang YJ.
        Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review.
        J Vasc Surg. 2007; 46: 906-912https://doi.org/10.1016/j.jvs.2007.07.025
        • bin Hsu R
        • CI Chang
        • Wu IH
        • et al.
        Selective medical treatment of infected aneurysms of the aorta in high risk patients.
        J Vasc Surg. 2009; 49: 66-70https://doi.org/10.1016/j.jvs.2008.08.004
        • Kan CD
        • Yen HT
        • ben Kan C
        • et al.
        The feasibility of endovascular aortic repair strategy in treating infected aortic aneurysms.
        J Vasc Surg. 2012; 55: 55-60https://doi.org/10.1016/j.jvs.2011.07.077
        • Sedivy P
        • Spacek M
        • el Samman K
        • et al.
        Endovascular treatment of infected aortic aneurysms.
        Eur J Vasc Endovasc Surg. 2012; 44: 385-394https://doi.org/10.1016/j.ejvs.2012.07.011
        • Dubois M
        • Daenens K
        • Houthoofd S
        • et al.
        Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases.
        Eur J Vasc Endovasc Surg. 2010; 40: 450-456https://doi.org/10.1016/j.ejvs.2010.07.017
        • Müller BT
        • Wegener OR
        • Grabitz K
        • et al.
        Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases.
        J Vasc Surg. 2001; 33: 106-113https://doi.org/10.1067/mva.2001.110356
        • Sörelius K
        • Budtz-Lilly J
        • Mani K
        • et al.
        Systematic review of the management of mycotic aortic aneurysms.
        Eur J Vasc Endovasc Surg. 2019; 58: 426-435https://doi.org/10.1016/j.ejvs.2019.05.004
        • bin HR
        • Chen RJ
        • Wang SS
        • et al.
        Infected aortic aneurysms: clinical outcome and risk factor analysis.
        J Vasc Surg. 2004; 40: 30-35https://doi.org/10.1016/j.jvs.2004.03.020
        • bin HR
        • FY Lin
        Infected aneurysm of the thoracic aorta.
        J Vasc Surg. 2008; 47: 270-276https://doi.org/10.1016/j.jvs.2007.10.017
        • bin HR
        • Chang CI
        • Chan CY
        • et al.
        Infected aneurysms of the suprarenal abdominal aorta.
        J Vasc Surg. 2011; 54: 972-978https://doi.org/10.1016/j.jvs.2011.04.024
        • Srelius K
        • Mani K
        • Bjrck M
        • et al.
        Endovascular treatment of mycotic aortic aneurysms: a European multicenter study.
        Circulation. 2014; 130: 2136-2142https://doi.org/10.1161/CIRCULATIONAHA.114.009481
        • Sörelius K
        • Wanhainen A
        • Furebring M
        • et al.
        Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair.
        Circulation. 2016; 134: 1822-1832https://doi.org/10.1161/CIRCULATIONAHA.116.024021
        • Luo CM
        • Chan CY
        • Chen YS
        • et al.
        Long-term outcome of endovascular treatment for mycotic aortic aneurysm.
        Eur J Vasc Endovasc Surg. 2017; 54: 464-471https://doi.org/10.1016/j.ejvs.2017.07.004
        • Nemoto Y
        • Hosoi Y
        • Hoshina K
        • et al.
        In situ reconstruction with extended debridement in patients with mycotic abdominal aortic aneurysms.
        Ann Vasc Dis. 2017; 10: 159-163https://doi.org/10.3400/avd.hdi.17-00001
        • Clough RE
        • Black SA
        • Lyons OT
        • et al.
        Is endovascular repair of mycotic aortic aneurysms a durable treatment option?.
        Eur J Vasc Endovasc Surg. 2009; 37: 407-412https://doi.org/10.1016/j.ejvs.2008.11.025